Classification Information
BrainSee is a Software platform as well as a SaMD (Software as Medical Device). The first version of BrainSee has recently received FDA approval for its clinical use to evaluate the risk of progression to Alzheimer's dementia in patients with mild cognitive impairment. BrainSee has 3 core underlying technological modules, each of which can be called BrainSee: 1) brain image analysis module, 2) AI module, and 3) fully automated, HIPAA-compliant, FDA approved Cybersecurity platform.
Computer and Scientific